Allergan

Allergan is a global pharmaceutical company that specializes in the development, manufacture, and commercialization of branded pharmaceuticals, biologics, and medical devices. Founded in 1948 by Henry R. Sloan and John D. Schafer, the company has its headquarters in Irvine, California, and is led by key people such as Brent Saunders and Paul Bisaro. Allergan operates in various markets, including the United States, Europe, Asia, and Latin America, and has partnerships with companies like Pfizer, Merck & Co., and GlaxoSmithKline. The company's products are used to treat a range of conditions, including glaucoma, migraines, and wrinkles, and are sold through various channels, including hospitals, pharmacies, and online platforms like Amazon and Walmart.

● History

Allergan was founded in 1948 by Henry R. Sloan and John D. Schafer as a small pharmaceutical company in Los Angeles, California. The company's early success was driven by its development of ophthalmic products, including eye drops and contact lens solutions, which were marketed through partnerships with companies like Bausch & Lomb and Alcon Laboratories. In the 1980s, Allergan expanded its product portfolio to include dermatological products, such as skin creams and acne treatments, which were developed in collaboration with companies like Johnson & Johnson and Procter & Gamble. The company's growth was further accelerated by its acquisition of Herbert Laboratories in 1985, which added psoriasis treatments and eczema creams to its product line, and its partnership with Biogen Idec to develop multiple sclerosis treatments.

● Products

Allergan's product portfolio includes a range of pharmaceuticals, biologics, and medical devices that are used to treat various conditions, including glaucoma, migraines, wrinkles, and acne. The company's Botox product, which is used to treat muscle spasms and cosmetic wrinkles, is one of its most well-known and successful products, and is marketed through partnerships with companies like Galderma and Merz Pharma. Allergan also markets Latisse, a prescription eyelash growth treatment that is used to treat hypotrichosis, and Juvederm, a dermal filler that is used to treat facial wrinkles and skin folds, which are developed in collaboration with companies like Ipsen and Medicis Pharmaceutical Corporation. The company's products are sold through various channels, including hospitals, pharmacies, and online platforms like CVS Pharmacy and Rite Aid.

● Research and Development

Allergan has a strong commitment to research and development, and invests heavily in the development of new products and technologies, in collaboration with companies like Pfizer, Merck & Co., and GlaxoSmithKline. The company's research and development efforts are focused on various therapeutic areas, including ophthalmology, dermatology, and neurology, and are conducted in partnership with institutions like Harvard University, Stanford University, and University of California, Los Angeles. Allergan has developed several innovative products, including Botox and Latisse, which have been approved by regulatory agencies like the US Food and Drug Administration and the European Medicines Agency. The company is also involved in various clinical trials, including studies on new treatments for glaucoma and migraine headaches, which are conducted in partnership with companies like Biogen Idec and Eli Lilly and Company.

● Acquisitions and Mergers

Allergan has been involved in several acquisitions and mergers throughout its history, including its acquisition of Herbert Laboratories in 1985 and its merger with Actavis in 2015, which added generic pharmaceuticals and biosimilars to its product line. The company has also acquired several other companies, including Inamed Corporation and Essex Pharmaceuticals, which have expanded its product portfolio and increased its presence in various markets, including the United States, Europe, and Asia. Allergan's acquisitions and mergers have been driven by its strategy to expand its product portfolio, increase its presence in various markets, and improve its competitiveness, and have been conducted in partnership with companies like Goldman Sachs and Morgan Stanley.

● Controversies

Allergan has been involved in several controversies throughout its history, including lawsuits related to its marketing practices and product safety, which have been filed by companies like Johnson & Johnson and Pfizer. The company has also faced criticism for its pricing practices, particularly with regard to its Botox product, which has been the subject of controversy and debate, and has been discussed by institutions like the US Congress and the European Parliament. Allergan has also been involved in several product recalls, including a recall of its textured breast implants due to concerns over cancer risks, which has been conducted in partnership with regulatory agencies like the US Food and Drug Administration and the European Medicines Agency.

● Corporate Affairs

Allergan is a publicly traded company that is listed on the New York Stock Exchange under the ticker symbol AGN. The company is led by a team of experienced executives, including Brent Saunders and Paul Bisaro, who have previously worked at companies like Schering-Plough and Merck & Co.. Allergan has a strong commitment to corporate social responsibility, and is involved in various philanthropic initiatives, including support for medical research and patient advocacy groups, which are conducted in partnership with institutions like the American Cancer Society and the National Multiple Sclerosis Society. The company is also a member of various industry associations, including the Pharmaceutical Research and Manufacturers of America and the Biotechnology Innovation Organization, which are dedicated to promoting the interests of the biopharmaceutical industry and advancing medical innovation. Category:Pharmaceutical companies